REVIVE-HF seeks to demonstrate superiority of the Revivent TC System to current guideline treatment for heart failure SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., developer of the first transcatheter device for left ventricular remodeling after a heart attack, today announced that Ralph Stephan […]
